In MF, dysregulation of TCR, TNFRSF/NF-κB, and JAK-STAT pathways is recurrently observed, demonstrating the involvement of all three “T cell lymphoma promoting” signalling pathways [33,34,35,36,37,38]. This evidence concerns the gene NFKB1 and T-cell non-Hodgkin lymphoma.